Physiology
The hypothalamus-pituitary-adrenal (HPA) system is a neuroendocrine system which is closely linked to stress in humans. This system is responsible for a rapid response to stressful stimuli and for the return to homeostasis through complex feedback mechanisms. Cortical brain regions, e.g. hippocampus and amygdala, are connected by glutamatergic pathways to the hypothalamus (1) . An activation of the hypothalamic neurons of the paraventricular nucleus by glutamate causes a release of corticotropin releasing hormone (CRH). By this, CRH is secreted into the hypophyseal portal circulation to reach the anterior pituitary, where it subsequently stimulates the release of adrenocorticotropic hormone (ACTH) into the circulation. ACTH stimulates the release of cortisol in the adrenals (see Figure 1 ). Serum cortisol concentration has to be sufficiently regulated within a physiological range. A hypercortisolism causes depression, diabetes, visceral obesity, or osteoporosis. Therefore, inhibition of cortisol secretion is an essential component of the regulation within this system. The inhibition is partly achieved by cortisol bindings to glucocorticoid receptors in the amygdala, hippocampus, hypothalamus, pituitary, and adrenals. However, it is also important to maintain cortisol concentrations above a critical threshold since cortisol may result in a disturbed memory formation or a life-threatening adrenal crisis (2, 3) .
Two types of corticoid receptors have been described based on biochemical and functional characteristics (4) . The mineralocorticoid receptor (MR) has a specificity in binding selectively cortisol. In the brain, MR is most The HPA system: Glutamate (hippocampus and amygdala) stimulates the release of CRH (hypothalamus), which stimulates the ACTH secretion (pituitary), and ACTH in turn stimulates cortisol secretion (adrenal cortex). Cortisol provides a feedback signal at all hierarchical levels via mineralocorticoid (MR) or glucocorticoid receptors (GR).
densely localized in hippocampal and septal neurons. While MR has a highaffinity to cortisol, its efficacy in the periphery and lower brain regions is limited by 11 β hydroxysteroid deshydrogenase 2, which converts intracellularly active cortisol into inactive cortisone. Conversely, the glucocorticoid receptor (GR) is widely distributed and represents the predominant binding site for cortisol in hypothalamus, pituitary, adrenals as well as in organs and tissues in the periphery. However, GR binds cortisol with a lower affinity as compared to MR. These receptor characteristics complement each other and put the MR and GR in a position to modulate HPA responses. MR appears to be sensitive to low and saturates at high cortisol concentrations. On the other hand, GR generates its dynamics at high, while it appears to be noneffective at low cortisol concentrations. It is known from the literature that cortisol binding to GR leads to an inhibitory effect on cortisol secretion (5).
However, it is unclear, how cortisol bound MR affects the HPA system.
The HPA system is a dynamical closed loop system, homeostatically regulated, and subject to a daily rhythm. In the second half of the night the HPA system is stimulated during REM sleep phases (6) . A maximum of cortisol and ACTH concentrations is attained in the early morning hours.
The hormones underlie a constant decay in the daytime. However, cortisol and ACTH concentrations are rising after meals or in a physical or psychological stress situation. During the first half of the night ACTH and cortisol concentrations are reaching a homeostatic level (for illustration see Figure   2 ). of foremost interest to the treatment of various diseases. This includes, for example, the defined hypo-or hypercortisolism, such as Addison's and Cushing disease. Also its the close connection to the energy and weight regulation (e.g. obesity, diabetes mellitus and metabolic syndrome) and to psychological illnesses such as depression is a profound motive to investigate the mechanisms of the HPA system regulation (7) . From an evolutionary point of view, it is widely accepted that a simple and durable mechanism had to provide a basis for a homeostatic regulated system. This led us to the following principle of homeostasis for the HPA system. Its interactions eventually result in a homeostatic state of cortisol (8) .
Principle of homeostasis
Rule 1 Cortisol binds at low concentrations to the MR and only at high concentrations to the GR.
Rule 2 Activated MR and GR operate in an opposing manner.
Rule 3 Cortisol raises its own serum concentration via activated MR, while it reduces it via activated GR.
Note that Rule 3 constitutes a positive feedback of MR on cortisol. In this way, we introduce a novel aspect in the concept of homeostasis.
The remaining part of this paper is organized as follows. Based on the three rules we develop a "homeostatic" mathematical model and prove in a strict sense that this system reaches a stable state over time, that is, in the present context, the system reaches a homeostatic state or set-point. Next
we establish a parameter estimation procedure which we bring forward to adapt the new model to clinical data. Finally, we discuss its clinical relevance and conclude.
Model
While quite a number of mathematical models of the glucose metabolism were developed and published (9) (10) (11) , only a small number of models of the HPA system can be found with rather different aims. The focus of these HPA models varies from the influence of the inner clock to the self-dynamic in this system (12, 13) . Despite several dissimilarities certain characteristics of the models are modeled along the same lines. The stimulation of CRH via ACTH on cortisol is constructed identically in previous HPA models. Additionally, the degradation rates of CRH, ACTH, and cortisol are assumed to be linear. Interestingly, almost all previous HPA models use only pure negative feedback elements (14) (15) (16) . The absence of positive feedback elements in these models turns out to be a shortcoming since there exist data indicating a positive stimulus in the HPA system (17). We will now present a new model, which includes positive as well as negative feedback elements and which is based on the three rules of homeostasis. Following the first rule of homeostasis (see box), cortisol (Z) binds to the high affine MR (R 1 ) and to the low affine GR (R 2 ). Cortisol and MR form a ligand-receptor complex C 1 and cortisol and GR a complex C 2 , respectively. Denoting the rates of reaction by k 1 , k −1 , k 2 and k −2 the reaction equation can be written as
Under common assumption of biochemical reaction kinetics and the law of mass action of competitive bindings (see (18)), we arrive at the following dose response relations
Here, z denotes the concentration of Z in the chemical equilibrium. The coefficients e 1 and e 2 represent the integrated maximal efficacies of all MRs and GRs localized in different brain regions (e.g. hippocampus, amygdala, hypothalamus, and pituitary) while
reflecting the binding affinity of MR and GR respectively (compare Figure   3 ). While the affinity of MR is higher than the affinity of GR, the inequality
Following the second rule of homeostasis (see box), we add the stimulation via the cortisol-MR complex and the inhibition of the cortisol-GR complex
We consider h as a feedback of cortisol in the HPA system (see Figure 3 ).
We pool the integrated influences of glutamate, CRH and ACTH from different brain regions in one molecular cue of the brain/pituitary compartment named Y (with a physiological interpretation as plasma ACTH) and suppose that the concentration y gives a positive stimulus on Z. By denoting the compartment transition of the adrenal cortex to the brain/pituitary compartment by a constant b 2 ∈ R + , we obtain the time dependent differential equation
where we assume Y to have a linear degradation rate b 1 ∈ R + . The function on Z we arrive at the closed system of two ordinary differential equations (ODE)
with some user prescribed initial conditions y 0 , z 0 ∈ R + . (1)).
equilibrium point which is asymptotically stable. A point x ∞ is called an equilibrium point for the differential equation
x starting in x(t 0 ) ∈ V remains in U for all t ≥ t 0 , otherwise it is called unstable. An equilibrium x ∞ is asymptotically stable if it is Lyapunov stable and, in addition, V can be chosen such that x(t) − x ∞ → 0 as t → ∞ for all x(t 0 ) ∈ V (see (19) ). From a physiological as well as mathematical point of view it is interesting to investigate the stability of the derived differential equation (3). The following theorem gives an answer in this direction. 
then there exists an unique point (y ∞ , z ∞ ), with y ∞ , z ∞ > 0, which is asymptotically stable. Moreover, the point (0, 0) is unstable.
In other words, provided the inequality (4) z. Thus, we either have one equilibrium point y (1) , z (1) = (0, 0) or three equilibrium points given by
with the setting
Now, inequality (4) states that g has a positive gradient at zero
and since g(0) = 0, there exists an ε > 0 so that g(z) > 0 for all z ∈ (0, ε].
Since the leading coefficient of g is negative, we deduce that lim z→∞ g(z) = −∞. Considering the curvature behavior of g, the differential equation (3) (with p ≡ 0) has a unique equilibrium point y (2) , z (2) with y (2) , z (2) > 0 and dg dz
Hence (3) (with p ≡ 0) has precisely one positive equilibrium point y (2) , z (2) . Next we verify that y (2) , z (2) is an asymptotic stable point (y ∞ , z ∞ ) of the differential equation (3) (with p ≡ 0). Here, it is sufficient to show that the real parts of the eigenvalues of the Jacobian of the right hand side of equation (3) with p ≡ 0 are genuinely negative in y (2) , z (2) (see (19) ). The eigenvalues (dependent only on z) of the Jacobian
are given by
For any z ∈ R the real part of λ 2 is genuinely negative Re(λ 2 (z)) < 0. Thus, it is sufficient to show that Re(λ 1 (z)) < 0 for z = z (2) . From
it is easy to deduce that
is valid. Consequently , Re(λ 2 (z)) < 0 and (y ∞ , z ∞ ) is an asymptotically stable point of the differential equation (3) is unstable since (4) together withḡ(0) =
Theorem 1 guarantees -under certain conditions that are consistent with the principle of homeostasis -the uniqueness of the asymptotic stable point (y ∞ , z ∞ ). Apart from this important statement, we are able to calculate the asymptotic stable point of the system of differential equations (3) ana-lytically. Furthermore, it should be mentioned that Theorem 1 holds even in the presence of a smooth external input function p with sufficient decay, e.g., p from equation (6) .
Parameter estimation
It should come with no surprise that the solutions y(t) and z(t) greatly vary with respect to the parameters b 1 , b 2 , b 3 , b 4 , e 1 , e 2 , K 1 , K 2 and with respect to the external input p(t). It is the goal of this section to show that these parameters may be chosen such that the resulting mathematical model closely approximates data stemming from clinical trails. While the constants The variation of y and z is therefore dependent on θ which is y( · ; θ) and z( · ; θ). Our goal is to solve the inverse problem: Find a vector θ min so that resulting concentrations y( · ; θ min ) and z( · ; θ min ) possess a best fit with respect to given concentrations of ACTH and cortisol given by clinical trials, among all possible vectors θ. Letỹ i andz j , withỹ i ,z j = 0, be clinical data of the blood plasma concentration of ACTH and blood serum concentration of cortisol at the times t i and τ j with i = 1, . . . , k and j = 1, . . . , , respectively. We assume that the data valuesỹ i andz j are associated with measurement errors, which are independent and normally distributed. To define a proper distance measure χ 2 : R 6 → R + , we make use of the standard maximum-likelihood-approach (see (21) ), that is
Here, σ y i and σ z i denote the standard deviations which are assumed to be given (see Figure 7 below).
At each iteration step the differential equation (3) has to be solved in order to evaluate the corresponding distance measure χ 2 . The wanted approximations of y and z are computed by means of a numerical ODE solver with respect to approximate initial conditions y(0, θ) = y 0 , z(0, θ) = z 0 .
Due to the nature of the underlying equations, we make use of the Matlab function ode23s, which is based on a modified Rosenbrock formula of order 2 (22) . The aim is now to minimize χ 2 with respect to θ χ 2 (θ min ) = min
To solve this unconstrained, nonlinear optimization problem, we employ a direct search method (a modified Nelder-Mead algorithm). The selected stop criterion ensures that θ min is a local minimum of χ 2 . In order to find the global minimum and avoid local minima, we started the process with several randomly chosen initial parameter sets θ new and chose the best set afterwards.
We performed a CRH challenge test for an evaluation of our mathematical model (see (23) ). In this clinical trial we injected twenty healthy subjects update θ by θ new solve ODE (3) to get y and z clinical data Before we perform the process of parameter estimation, the external input p of CRH on ACTH (i.e. y) has to be identified. In the considerations for estimating the external input we only take three assumptions into account. First the separation of external input and feedback and secondly the feedback on ACTH is only caused by cortisol. Thirdly, we assume that the external input p can be represented with some b 5 ∈ R + and α ∈ R + by the exponential function
which is a natural impulse (CRH) response (ACTH) curve (see for instance (11)). Since the effect of CRH on ACTH is unknown, the parameters b 5 and α are to be estimated first. We consider y from the system of differential equations (3) 
Discussion and conclusion
We developed a system of differential equations (3) for plasma ACTH and serum cortisol that fulfills the postulated rules of homeostasis. We proved that, under mild assumptions, the system reaches a stable state over time.
The fact that the system stabilizes in a well-defined state resembles the existence of a set-point for physiological systems that obey the principles of homeostasis. Despite its appealing simplicity, we were able to tune the parameter of the model, such that it fits remarkable well to clinical data.
We deliberately abstained to add further compartments to our math- One should notice that the asymptotic stable point (y ∞ , z ∞ ) could be used as an indicator for disorders such as depression, obesity, and diabetes.
In (8) we tested a slightly modified system of differential equations referring to various clinical trials. Despite the simple structure of that system of differential equations, the process of parameter estimation performs strongly to various even pathological-clinical trials. Especially in pathological cases our model is in high agreement with clinical data, while purely negative models e.g. (8, 17, 23) result in a poor approximation. Thus, the presented model has a wider scope of validity than purely negative feedback systems.
The approach to compute the parameter vector θ min enables us to classify the feedback parameters, to calculate the asymptotic stable point (y ∞ , z ∞ ), and to identify potential pathological states in any subject individually.
Receptors with high and low affinities acting on the same ligand can be found throughout the entire organism (25). It therefore appears plausible that other control systems in the organism are regulated by a similar mechanism. There is physiological evidence that the rules of homeostasis and the structure of our mathematical modeling might be transferred to other homeostatic biological systems (7, 8) .
